Macquarie Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Macquarie Group's MRNA Position: Q3 2026 in Review
Macquarie Group increased its Moderna (MRNA) stake by 510% in Q3 2026, buying an estimated $2.08M and bringing the position to 23,098 shares worth $4.45M. The position accounts for 0.02% of the portfolio, ranked #440.
Macquarie Group first reported a position in MRNA in Q2 2020 and has held it in 26 quarters since. The position peaked at $356M in Q2 2021. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Macquarie Group held 23,098 shares of Moderna worth $4.45M as of Q3 2026.
- Macquarie Group bought 19,311 Moderna shares in Q3 2026, an estimated $2.08M.
- Moderna made up 0.02% of Macquarie Group's portfolio in Q3 2026, its #440 holding.
- Macquarie Group first reported a position in Moderna in Q2 2020 and has held it in 26 quarters since.
- Macquarie Group's Moderna position peaked at $356M in Q2 2021.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Macquarie Group's 13F filing for Q3 2026, filed 13 Nov 2026.